- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04280159
Modern Hybrid Imaging in Patients With OSCC (PETOSCC)
19. februar 2020 oppdatert av: Wuerzburg University Hospital
Modern Hybrid Imaging for Staging and Monitoring Patients With Oral Squamous Cell Carcinoma
Prospective diagnostic study to determine the diagnostic accuracy of preoperative 18F--fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in detecting local tumor extent, cervical lymph node metastases and distant metastases/secondary primary tumor.
Studieoversikt
Status
Fullført
Forhold
Studietype
Observasjonsmessig
Registrering (Faktiske)
265
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Würzburg, Tyskland, 97070
- Department of Cranio- and Maxillofacial Surgery
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Prøvetakingsmetode
Sannsynlighetsprøve
Studiepopulasjon
Patient with squamous cell carcinoma of the oral cavity,
Beskrivelse
Inclusion Criteria:
- Histopathological proven head and neck carcinoma
- Written inform consent
- 18 years of age
Exclusion Criteria:
- Cancer of unknown primary
- En-bloc resection of lymph node levels
- Uncertainties regarding the removed lymph node levels
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Diagnostic accuracy of FGD-PET/CT to detect the primary tumor
Tidsramme: 2013-2018
|
Visual assessment of FDG-PET/CT will be performed according to current guidelines.
The localization, expansion, and infiltration of osseous structures will be recorded.
The outcome measure is the correct diagnosis (1 = correct; 0 = false) with regards to the histopathological analysis.
The outcome measure will then be used to calculate the diagnostic accuracy of FDG-PET/CT to detect the primary tumor.
|
2013-2018
|
|
Diagnostic accuracy of FGD-PET/CT to detect lymph nodes metastases
Tidsramme: 2013-2018
|
Visual assessment of FDG-PET/CT will be performed according to current guidelines.
The presence and number of nodal metastasis will be recorded for each cervical lymph node level.
The outcome measure is the correct diagnosis (1 = correct; 0 = false) with regards to the histopathological analysis.
The analysis will be performed on a patient level (lymph node metastasis yes/no), on the nodal metastatic involvement of cervical sides and lymph node levels.
The outcome measure will then be used to calculate the diagnostic accuracy of FDG-PET/CT to detect lymph node metastases.
|
2013-2018
|
|
Diagnostic accuracy of FGD-PET/CT to detect distant lymph node metastases.
Tidsramme: 2013-2018
|
Visual assessment of FDG-PET/CT will be performed according to current guidelines.
The presence, localization and number of distant nodal metastasis will be recorded.
The outcome measure is the correct diagnosis (1 = correct; 0 = false) with regards to the histopathological analysis.
The outcome measure will then be used to calculate the diagnostic accuracy of FDG-PET/CT to detect lymph node metastases.
|
2013-2018
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Diagnostic accuracy of MRI to detect the primary tumor
Tidsramme: 2013-2018
|
Visual assessment of MRI will be performed according to current guidelines.
The localization, expansion, and infiltration of osseous structures will be recorded.
The outcome measure is the correct diagnosis (1 = correct; 0 = false) with regards to the histopathological analysis.
The outcome measure will then be used to calculate the diagnostic accuracy of MRI to detect the primary tumor.
|
2013-2018
|
|
Diagnostic accuracy of MRI to detect lymph nodes metastases
Tidsramme: 2013-2018
|
Visual assessment of MRI will be performed according to current guidelines.
The presence and number of nodal metastasis will be recorded for each cervical lymph node level.
The outcome measure is the correct diagnosis (1 = correct; 0 = false) with regards to the histopathological analysis.
The analysis will be performed on a patient level (lymph node metastasis yes/no), on the nodal metastatic involvement of cervical sides and lymph node levels.
The outcome measure will then be used to calculate the diagnostic accuracy of MRI to detect lymph node metastases.
|
2013-2018
|
|
Diagnostic accuracy of CT to detect the primary tumor
Tidsramme: 2013-2018
|
Visual assessment of CT will be performed according to current guidelines.
The localization, expansion, and infiltration of osseous structures will be recorded.
The outcome measure is the correct diagnosis (1 = correct; 0 = false) with regards to the histopathological analysis.
The outcome measure will then be used to calculate the diagnostic accuracy of CT to detect the primary tumor.
|
2013-2018
|
|
Diagnostic accuracy of CT to detect lymph nodes metastases
Tidsramme: 2013-2018
|
Visual assessment of CT will be performed according to current guidelines.
The presence and number of nodal metastasis will be recorded for each cervical lymph node level.
The outcome measure is the correct diagnosis (1 = correct; 0 = false) with regards to the histopathological analysis.
The analysis will be performed on a patient level (lymph node metastasis yes/no), on the nodal metastatic involvement of cervical sides and lymph node levels.
The outcome measure will then be used to calculate the diagnostic accuracy of CT to detect lymph node metastases.
|
2013-2018
|
|
Diagnostic accuracy of CT to detect distant lymph node metastases.
Tidsramme: 2013-2018
|
Visual assessment of CT will be performed according to current guidelines.
The presence, localization and number of distant nodal metastasis will be recorded.
The outcome measure is the correct diagnosis (1 = correct; 0 = false) with regards to the histopathological analysis.
The outcome measure will then be used to calculate the diagnostic accuracy of CT to detect lymph node metastases.
|
2013-2018
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Urs Müller-Richter, MD, DDS, PhD, Dpt. of CMF, University Hospital Wuerzburg
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
28. juni 2013
Primær fullføring (Faktiske)
31. desember 2018
Studiet fullført (Faktiske)
31. desember 2018
Datoer for studieregistrering
Først innsendt
4. februar 2020
Først innsendt som oppfylte QC-kriteriene
19. februar 2020
Først lagt ut (Faktiske)
21. februar 2020
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
21. februar 2020
Siste oppdatering sendt inn som oppfylte QC-kriteriene
19. februar 2020
Sist bekreftet
1. februar 2020
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- PETOSCC
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .